Benzazepine compound

Details for Australian Patent Application No. 2011225108 (hide)

Owner Astellas Pharma Inc.

Inventors Koshio, Hiroyuki; Asai, Norio; Takahashi, Taisuke; Shimizu, Takafumi; Nagai, Yasuhito; Kawabata, Keiko; Thor, Karl Bruce

Agent Davies Collison Cave

Pub. Number AU-A-2011225108

PCT Pub. Number WO2011/111817

Priority 61/313133 12.03.10 US

Filing date 11 March 2011

Wipo publication date 15 September 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/04 Drugs for disorders of the metabolism

A61P 13/00 Drugs for disorders of the urinary system

A61P 13/02 Drugs for disorders of the urinary system

A61P 15/10 Drugs for genital or sexual disorders

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/111817 Priority application(s): WO2011/111817

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011225115-Method for proliferating cardiomyocytes using micro-RNA

2011225104-Drive device for moving bodies